Development of Cognitive Assessment Tools in Parkinson Disease

NCT00556764 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: [123I] IBVM and SPECT imaging
DRUG: Subjects will undergo the 123-I IBVM imaging visit

Sponsor

Institute for Neurodegenerative Disorders

Collaborators

[object Object]
[object Object]